MOLECULAR DIVERSITY OF CYTOKERATINS - SIGNIFICANCE FOR CELL AND TUMOR DIFFERENTIATION

被引:0
|
作者
MOLL, R
机构
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Normal and transformed epithelial cells are characterized by the expression of a distinct class of intermediate filaments (IFs), the cytokeratin (CK) filaments. Their constituents, the CKs, comprise a complex multigene family of related proteins which can be subdivided into two sequence types (I and II). In the various epithelial cell types (excluding trichocytes), 19 different CK polypeptides (CKs 1-9) have been distinguished until recently. An additional cytoskeletal polypeptide of M(r) 46 000 has been detected, by gel electrophoresis and by immunocytochemistry, in certain types of epithelia including gastric foveolar epithelium, small and large intestinal epithelium, urothelium, and epidermal Merkel cells. On the basis of its biochemical properties and considerable sequence homologies with several type I CKs, this new cytoskeletal protein is suggested to be included in the catalogue of human CKs as CK 20. The various CK polypeptides, as detected by gel electrophoretic and/or immunocytochemical analysis, are expressed in different epithelia and carcinomas in various combinations in a differentiation-dependent manner. Moreover, co-expressions of CKs with other IF classes (vimentin, neurofilaments, glial filaments) are also characteristic of certain epithelial differentiation lineages. Both non-neoplastic epithelial alterations as well as malignant transformation may result in similar modifications of the IF expression profiles although there is a considerable tendency of conservativity. In several instances, a reduced degree of differentiation is paralleled by an increased complexity of the IF protein pattern. CK (and IF) typing can be successfully used in the tracing of developmental lineages as well as in the histological differential diagnosis of primary and metastatic carcinomas. Certain CK polypeptides (CKs 5, 6, 14, 16, 17) identify squamous cell carcinomas including poorly differentiated ones, while other CKs, including CK 20, are typical of primary and metastatic urothelium-derived carcinomas. Among simple-epithelial tumors, CK analysis is of potential diagnostic value in the distinction of mesotheliomas from adenocarcinomas, the discrimination of different carcinomas within the gastrointestinal tract, and the distinction of certain gastrointestinal carcinomas from other adenocarcinoma types including breast and lung carcinomas. Among the individual CKs, CKs, 5, 7, 13, 14, 19, and 20 appear to be particularly useful for diagnostic purposes. An important task in the future will be the development of additional monospecific CK-antibodies, particularly such which work on routine paraffin sections.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 50 条
  • [21] Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories
    Pan, Xiu-wu
    Chen, Wen-jin
    Xu, Da
    Guan, Wen-bin
    Li, Lin
    Chen, Jia-xin
    Chen, Wei-jie
    Dong, Ke-qin
    Ye, Jian-qing
    Gan, Si-shun
    Zhou, Wang
    Cui, Xin-gang
    ISCIENCE, 2023, 26 (12)
  • [22] Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
    Huang, Suning
    Chen, Gang
    Dang, Yiwu
    Chen, Long-Hua
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [23] Non small cell lung cancer and circulating tumor cell: A different expression of EpCam and cytokeratins
    Rossi, Elisabetta
    Manicone, Mariangela
    Facchinetti, Antonella
    Aieta, Michele
    De Faveri, Stefania
    Scaini, Maria Chiara
    Possidente, Luciana
    Terstappen, Leon W. M. M.
    Zamarchi, Rita
    CANCER RESEARCH, 2015, 75
  • [24] CYTOKERATINS AS MOLECULAR MARKERS IN THE EVALUATION OF THE PRECISE DIFFERENTIATION STAGE OF HUMAN GINGIVAL EPITHELIUM RECONSTITUTED INVITRO
    GOSSELIN, F
    MAGLOIRE, H
    JOFFRE, A
    PORTIER, MM
    ARCHIVES OF ORAL BIOLOGY, 1990, 35 : S217 - S221
  • [25] STUDIES ON THE EXPRESSION OF CYTOKERATINS DURING DEVELOPMENT AND DIFFERENTIATION
    ROYAL, A
    LAMPRON, C
    OUELLETTE, T
    LUSSIER, M
    LAPOINTE, L
    EXPERIMENTAL BIOLOGY, 1987, 46 (03): : S6 - S6
  • [26] Clinical utility of cytokeratins as tumor markers
    Barak, V
    Goike, H
    Panaretakis, KW
    Einarsson, R
    CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 529 - 540
  • [27] On the use of cytokeratins 7 and 20 in the differentiation between transitional cell carcinoma and prostate adenocarcinoma
    Yaziji, H
    Davie, PL
    Gown, AM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (01) : 159 - 160
  • [28] CYTOKERATINS AS MARKERS OF DUCTAL CELL-DIFFERENTIATION AND ISLET NEOGENESIS IN THE NEONATAL RAT PANCREAS
    BOUWENS, L
    WANG, RN
    DEBLAY, E
    PIPELEERS, DG
    KLOPPEL, G
    DIABETES, 1994, 43 (11) : 1279 - 1283
  • [29] Glioblastoma with adipocyte-like tumor cell differentiation - Histological and molecular features of a rare differentiation pattern
    Rickert, Christian H.
    Riemenschneider, Markus J.
    Schachenmayr, Walter
    Richter, Hans-Peter
    Bockhorn, Juergen
    Reifenberger, Guido
    Paulus, Werner
    ACTA NEUROPATHOLOGICA, 2008, 116 (03) : 353 - 353
  • [30] CYTOKERATINS AND TUMOR PROGRESSION IN THE UTERINE CERVIX
    NAIR, SA
    LAKSHMI, S
    KANNAN, S
    NAIR, MK
    PILLAI, MR
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (02) : 131 - 138